Baird’s Biotechnology & Pharmaceuticals practice is a recognized leader providing capital raising advisory, M&A advisory and strategic alternative solutions to public and private clients. Our senior leadership’s strategic insights into large pharma, biotech, and venture capital communities mean that we have our finger on the pulse of equity, private placement and M&A deals in the market.
We are focused on delivering flawless execution and long-term client support, leveraging our strong investor and buyer relationships. We are a trusted and prominent advisor for companies, with an exceptional track record of delivering successful outcomes for our clients through deep industry expertise, teamwork and a commitment to excellence.
View More Transactions
News & Insights
Staring the year off strong, Baird’s European Healthcare team has successfully signed four deals in the past four months.
Baird and Strategas break down what the Inflation Reduction Act Means for Healthcare companies and investors.